Although risk for inflammation in the pancreas, liver problems, or thyroid cancer was not found to be higher in the patients with diabetes treated with GLP-1s, the study did show the treated group had a 49 percent greater chance of developing diabetic retinopathy, the leading cause of blindness in the United States
Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data
102 The FDA set several usage restrictions upon the initial approval of Tanzeum (albiglutide), reflecting considerations of suitability and safety for specific patient groups
DSouza predicted that in the future there would be a small group of the unenhanced
At Bourne End Pharmacy , our clinical team is here to guide you with expert advice, personalised care, and medication reviews
Work with your healthcare team to figure out which meds work best for you